Also known as: Deaths / Death / Mortalities / O/E - dead / Death NOS

DrugDrug NameDrug Description
DB06681BelataceptBelatacept is a soluble fusion protein, which links the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1). Structurally, abatacept is a glycosylated fusion protein with a MALDI-MS molecular weight of 92,300 Da and it is a homodimer of two homologous polypeptide chains of 357 amino acids each. It is produced through recombinant DNA technology in mammalian CHO cells. The drug has activity as a selective co-stimulation modulator with inhibitory activity on T lymphocytes. It is approved for the treatment of rheumatoid arthritis. Belatacept selectively blocks the process of T-cell activation. It was developed by Bristol-Myers-Squibb. It differs from abatacept (Orencia) by only 2 amino acids. FDA approved on June 15, 2011.
DrugDrug NamePhaseStatusCount
DB00169Cholecalciferol2 / 3Completed1
DB00115Cyanocobalamin2 / 3Completed1
DB00158Folic Acid2 / 3Completed1
DB00741Hydrocortisone2 / 3Unknown Status1
DB02701Nicotinamide2 / 3Completed1
DB00165Pyridoxine2 / 3Completed1
DB00140Riboflavin2 / 3Completed1
DB00152Thiamine2 / 3Completed1
DB00162Vitamin A2 / 3Completed1
DB00126Vitamin C2 / 3Completed1
DB04899Nesiritide3Unknown Status1
DB11248Zinc gluconate3Completed1
DB12768BCG vaccine4Recruiting1
DB00633Dexmedetomidine4Active Not Recruiting1
DB09153Sodium Chloride4Active Not Recruiting1
DB00162Vitamin A4Completed3
DB00162Vitamin A4Terminated1
DB00162Vitamin A4Unknown Status1
DB047895-methyltetrahydrofolic acidNot AvailableCompleted1
DB13152Coagulation Factor IX HumanNot AvailableRecruiting1
DB00736EsomeprazoleNot AvailableUnknown Status1
DB00158Folic AcidNot AvailableCompleted1
DB01024Mycophenolic acidNot AvailableNot Yet Recruiting1
DB00864TacrolimusNot AvailableNot Yet Recruiting1
DB00302Tranexamic AcidNot AvailableUnknown Status1
DB01593ZincNot AvailableCompleted2